CONTACT
- ICPD® · Ordway Research Institute
1365 Washington Avenue
Suite 201
Albany, NY 12206-1072 - Tel: (518) 429-2600
Fax: (518) 429-2601
- ICPD Presents Oritavancin Dose Regimen Justification for Novel Short-Course Dosing Regimens for Complicated Skin and Skin Structure Infections
- ICPD Announces Initiative to Address US Food and Drug Administration Challenge Regarding Trial Design for Community-Acquired Respiratory Tract Infections
- ICPD Presents at IDSA-FDA Co-Sponsored Community-Acquired Pneumonia Clinical Trial Workshop
- Method for the Study of Sinusitis Developed by ICPD Scientists Cited in FDA Industry Guidance
- Commentary on Drug Development by ICPD’s Dr. Sujata M. Bhavnani Published in Nature Reviews Drug Discovery
- Ambrilia Biopharma Showcases ICPD Analysis Results
- ICPD Announces Move to New Facility
- ICPD Study Examining Adverse-Drug-Event Costs Gains National Recognition
- ICPD Announces Partnership with JMI Laboratories